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Summary    
Objective   
To investigate what proportion of a regional cohort of cooled infants with neonatal encephalopathy, 
develop epilepsy (ILAE-definition and AED) up to 8 years of age.  
Methods                                                                                                                                                               
From 2006-2013, 151 infants, with perinatal asphyxia underwent 72 hours cooling. Clinical and aEEG 
with single-channel EEG verified neonatal seizures were treated with anti-epileptic drugs (AEDs). 
Brain MRI was assessed using a 0-11 severity score.  
Post-neonatal seizures, epilepsy-rates and AED treatments were documented. 134 survivors were 
assessed at 18-24 months; adverse outcome was defined as death or Bayley-III composite 
Cognition/Language or Motor scores <85 and/or severe cerebral palsy or severely reduced 
vision/hearing. Epilepsy-rates in 103 children age 4-8 years were also documented.  
Results  
aEEG confirmed seizures occurred pre-cooling in 77/151(57%) neonates; 48% seized during and/or 
after cooling and received AEDs. Only one infant was discharged on AEDs. At 18-24 months one-third 
of infants had adverse outcome including 11% mortality. At 2 years, 8(6%) infants had an epilepsy 
diagnosis (ILEA definition), of whom 3(2%) received AEDs. Of the 103 4-8 year olds, 14(13%) had 
developed epilepsy, with 7(7%) receiving AEDs. Infants/children on AEDs had higher MRI scores than 
those not on AEDs, (median (IQR) 9(8-11) vs. 2(0-4)) and poorer outcomes. Nine of 14 children with 
epilepsy had CP(64%) compared to 13/120(11%) without epilepsy and 10/14(71%) children with 
epilepsy had adverse outcomes versus 23/120(19%) survivors without epilepsy. The number of 
different AEDs given to control neonatal seizures, aEEG severity pre-cooling and MRI scores predicted 
childhood epilepsy.  
Significance                                                                                                                                                           
We report, in a regional cohort of infants cooled for perinatal asphyxia, 6% with epilepsy at 2 years 
(2% on AEDs) increasing to 13%(7% on AEDs) at early school age.  These AED rates are much lower 
than reported in the cooling trials even adjusting for our cohort´s milder asphyxia. Long-term 
follow-up is needed to document final epilepsy-rates.  
Key words: Epilepsy, seizure, ILAE, AED, hypothermia, hypoxia-ischemia, newborn, childhood 
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Key Points 
1. 151 infants with moderate or severe perinatal asphyxia treated with therapeutic 
hypothermia, 75% had neonatal seizures confirmed on single-channel 
electroencephalogram (EEG) and amplitude integrated EEG before, during or after cooling.  
2. Seizures occurred in 43% of infants during hypothermia treatment; only 1 of 134 survivors 
was still on antiepileptic drugs at discharge. 
3. The epilepsy rate (ILAE definition) increased from 6% at 2 years to 13% at 4-8 years with 2% 
and 7% respectively on medication.  
4. Of children with epilepsy, 64% had cerebral palsy as compared to 11% with CP among the 
120 children without epilepsy in the cohort.  
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Introduction  
 Childhood epilepsy affects cognitive performance, life quality and life expectancy. The prevalence of 
epilepsy requiring anti-epileptic drugs (AEDs) in patients of any age is about 0.97% in the UK1 while 
the overall rate of seizures under the age of four is 0.2%1. In infants who suffer hypoxic-ischemic 
encephalopathy (HIE)2 the post-neonatal epilepsy rate at 18 months when defined as needing 
regular AEDs, is reported to be 15-16%3-6  both in infants who did and did not receive therapeutic 
hypothermia (TH).  At school age, rates are reported to be 10%-16%7. Recently the International 
League Against Epilepsy (ILAE) definition of epilepsy was published8, namely two or more 
unprovoked seizures at least 24 hours apart or a formal epilepsy syndrome diagnosis. In our paper 
we present epilepsy rates both according to the definition used in earlier HIE follow-up papers and 
according to ILAE.  
The relatively novel treatment of TH, has significantly reduced the relative risk of the combined 
adverse outcome, death and disability in infants with HIE at birth; 0.75 (95% confidence interval, CI, 
0.68-0.83)9. Cooling to core temperature 33.5˚C for 72h after moderate or severe perinatal asphyxia 
is now standard of care in developed countries.  Our centre has cooled infants as a part of feasibility 
studies, randomised trials or registered follow-up programs since 19983; 5; 10-12. We introduced TH as 
a standard treatment in December 2006 when recruitment to the TOBY trial5 ended. The aim of our 
current study was to examine the incidence of early childhood seizures in a cohort of cooled infants 
treated in a manner representative of clinical cooling practices for perinatal asphyxia of mostly 
moderate severity and seizure management in a single regional tertiary referral centre in the UK.                                                                                                                                                 
Methods 
This study has waiver consent and ethical permission (09/H016/3) to use prospectively collected 
anonymised clinical data from the Bristol cooling database  
Inclusion and exclusion criteria for cooling 
Our tertiary cooling centre serves 8 level II regional hospitals and 165 infants received TH between 
December 2006 and October 2013. Infants born at ≥36 gestational age (GA) were assessed as eligible 
for cooling using the three (A, B and C) CoolCap and later TOBY trial entry criteria3; 5; A: metabolic, B: 
neurological and C: modified amplitude integrated electroencephalographic (aEEG) criteria.  
A: fulfilment of at least one of: 1) Apgar score ≤5 at 10min, 2) continued need for assisted ventilation 
10min after birth, 3) pH <7.0 within the first hour after birth, 4) base deficit ≥16mmol/L within the 
first hour after birth.  
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B: clinical presentation of moderate or severe encephalopathy having reduced consciousness 
including being lethargic or stuporous, and in addition at least one of the following: hypotonia, 
abnormal reflexes, an absent or weak suck and clinical seizures.   
C:  Moderately or severely abnormal amplitude-integrated electroencephalogram (aEEG) 
background voltage pattern within 6h of birth: (i.e. moderate depression with lower band <5µV and 
upper band >5µV or severe depression with lower band <5µV and upper band <10µV3; 13) or single-
channel EEG confirmed seizures lasting at least 3min within 1 hour with any background pattern. 
Since 2008, we also recruited encephalopathic infants using modified cooling entry criteria for 20% 
of patients14 i.e. including infants with early postnatal collapse, major extracerebral or intracerebral 
or intraventricular haemorrhage, a diagnosis requiring major surgery, a cardiac diagnosis, mild 
prematurity (gestational age 34-36 weeks) or starting TH late from 6 to 12h after birth. In the 
current paper, 19% of infants who were cooled had these modified entry criteria.  Exclusion criteria 
were infants <2nd weight centile for GA, on-going bleeding and very poor condition so treatment was 
deemed futile. 
 
Cooling management 
When cooling entry criteria A and B were fulfilled (usually within 1 hour of birth), passive cooling 
(removing any external heating and infant’s rectal temperatures closely monitored) or active 
cooling (using cooling equipment) was initiated while aEEG monitoring was started. The “worst” 
aEEG pattern seen lasting at least 30min within 6h of birth classified the infant for cooling to 33.5°C 
for 72h or not. TH was maintained using either a servo-controlled body wrap circulated with water, 
(Criticool, Charter Kontron Ltd. Milton Keynes, UK n=145), a servo-controlled cooling mattress 
Tecotherm Neo (n=16, Inspiration Healthcare Ltd. Leicester, UK) or using a manually controlled 
head-cooling system at a rectal temperature of 34.5°C (CoolCap, Natus Medical Inc. Seattle, USA) 
n=4. All infants were sedated with morphine, typically starting at 20µg/kg/hour, the dose being 
adjusted according to clinical needs during TH and intensive care. This practice is based on 
experimental evidence demonstrating that cooling without sedation compromises the 
neuroprotective effect of cooling15.  
Seizures, aEEG monitoring and anti-convulsant treatment during cooling 
All infants underwent single-channel aEEG using cross-brain C3-C4 electrode placement monitoring 
(CFM Olympic monitor, Natus, Seattle, USA) from before cooling, throughout the whole cooling 
treatment until post-rewarming. aEEG applies an algorithm to the raw EEG signal of time 
compression, high and low pass filtering and amplitude weighting onto a semi-logarithmic voltage 
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scale16. Sub-dermal needle electrodes (27G, Natus Medical Inc. Seattle, USA) were used for all 
infants without adverse effects including those who were cooled with a CoolCap covering the head. 
Clinically apparent seizures were treated, as well as prolonged (≥3min), single or repetitive electrical 
seizures or status epilepticus; seizure activity lasting ≥30min seen on the aEEG and confirmed 
running the trace as single-channel EEG. aEEG monitoring was used both to diagnose seizures and 
guide anticonvulsant treatment. A standard escalating AED protocol was used from 2006-2013: 
phenobarbitone bolus (20mg/kg)X1 or x2 phenytoin (20mg/kg)x1 clonazepam (100 
microgram/kg)X1 or occasionally midazolam infusion at 0.1-0.4mg/kg/h17 lidocaine infusion 
(loading dose of 2mg/kg, followed by continuous infusion at a rate of  6-2mg/kg/h)18. In one case, 
levitracetam and carbamazepine were used, and in another three cases, rectal paraldehyde 
(0.4ml/kg in dilution) successfully controlled refractory seizures. The aEEG traces and single-channel 
EEG (when seizures were suspected), were reviewed in real time for clinical decision-making as well 
as post-discharge for further analysis.  
The standard rewarming rate from 33.5-36.5°C was 0.4°C/h. When aEEG and EEG confirmed seizure 
activity occurred during rewarming (n=14), rewarming was stopped and core temperature reduced 
by 1°C while AEDs were administered to control seizures followed by rewarming at a slower rate of 
0.1-0.2°C/h. Five infants, who needed more than two AEDs to control seizures during cooling, were 
empirically rewarmed slowly. This clinical practice was developed in our newborn pig asphyxia 
model of post-hypoxic seizures 19, described in a clinical practice paper20 and included in our local 
cooling guidelines.  
After discharge from hospital, “Children who presented with two or more unprovoked seizures at 
least 24 hours apart, or had a formal epilepsy syndrome diagnosis were classified as having epilepsy.” 
Brain magnetic resonance imaging (MRI)  
Infants were routinely scheduled for a brain MRI scan between 7 to 10 days. T1-, T2- and diffusion-
weighted images were reviewed by a perinatal neurologist, our MR specialist (FC), who was only 
aware of the main diagnosis and age at scan. The scans were scored by summing up the severity 
grading developed by Rutherford et al21 for basal ganglia and thalami (BGT, score 0-3), white matter 
(WM, score 0-3), cortex (CX, score 0-3), and posterior limb of internal capsule (PLIC, score 0-2) where 
0 is no injury and 3 is maximum injury; giving a total maximum lesion injury score of 11. This is 
different from how the scoring was used in the nested MRI study from the TOBY cooling trial where 
cortical injury score was not included and BGT, WM and PLIC scores were not summated21. 
Clinical follow-up and data collection 
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Surviving children attended routine follow-up appointments at 6 weeks, 6, 12 and 24 months or 
more frequently as required. All children were scheduled for an assessment using the Bayley Scales 
of Infants and Toddler Development, 3rd edition (Bayley-III) (mean for normal =100, 1 standard 
deviation=15) at 18 months by a senior neurodevelopmental physiotherapist unaware of clinical 
details. Bayley-III motor composite and the average of cognitive and language composite (CLC) 
scores <85 were one of the criteria used to identify those children with adverse outcome. We have 
previously presented Bayley-III cut-off scores <85 to be comparable with Bayley-II scores of <70 in 
identifying severe delay22.  Bayley-II <70 was the cut-off used for an adverse outcome in previously 
published cooling trials22. A formal diagnosis of cerebral palsy(CP) was made at 2 years. Type of CP 
was classified according to the Surveillance of Cerebral Palsy in Europe and graded using the Gross 
Motor Function Classification Scale (GMFCS): levels 3-5 were considered severe, grades 1-2 mild and 
a score of 0 was given to infants without CP. GMFCS grades 3-5 were used as an adverse outcome 
for the binary analysis, as in the earlier trials of TH. 
Information about any post-neonatal seizures, EEG findings and medications was gathered from 
available local and regional outpatient appointments, relevant discharge notes from inpatient stays 
or the accident and emergency departments for children in this region since birth. In the earlier 
neonatal literature, receiving regular AEDs at the age of 2 years was used as a proxy definition of 
epilepsy3; 4; 6. We present this information in addition to defining epilepsy according to ILAE8. 
Information on seizures occurring after 2 years of age was collected for the 103 children born before 
2012 (now aged up to 8 years).  
When a binary outcome was used in the analysis, composite adverse outcome was death or 
disability defined as having at least one of: Bayley-III scores <85 for the average CLC or motor 
composite, severe CP (GMFCS 3-5), severe visual deficits or severe bilateral hearing loss. Epilepsy 
was not used as a marker of severe outcome for this study. Children who did not have Bayley 
assessments (n=13) were given an estimated binary outcome from the median value for the 134 
survivors. On reviewing the neonatal data of these 13 children, this outcome was concordant with a 
low severity score at birth and needing no or only 1 AED in the neonatal period.  
Statistical analysis 
Non-parametric data were presented as median (interquartile range, IQR) as mostly non-normal 
distributions were identified in our data. Two groups comparison was undertaken using “N-1” chi 
square test since sample sizes were small or moderate.  
Results 
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Between 2006 -2013, 165 infants received TH; however, on review of entry criteria 14(8%) were 
found to have a normal aEEG background pattern (Continuous Normal Voltage;CNV) without seizure 
activity prior to cooling hence failing “entry criteria C”. None seized, all had normal outcomes and 
they were not included in the main analyses. Their clinical, cooling and aEEG data are reported 
separately in tables 1 and 2 together with the 151 correctly recruited infants.  Seventeen infants 
died (11%)(13 before rewarming) of whom 16 seized. At 2 years, 33 survivors(22%) had adverse 
developmental outcomes, hence death and disability combined was 33%. Outcome varied with the 
aEEG severity classification before 6h; 6% had poor outcome in the CNV+seizure group and 87% in 
the Flat Trace group (table 2).   
Epilepsy at 2 years and at 4-8 years  
Of 134 survivors, only 8(6%) presented with seizure activity between neonatal discharge and 2 years, 
fulfilling the ILAE epilepsy definition but only three infants (2%) were on AEDs (table 3). Of the 103 
infants who reached 4-8 years, 6 more fulfilled the ILAE epilepsy definition and four more, (7% of 
survivors) were now on AEDs. Five of the 14 with epilepsy had another diagnosis in addition to 
evidence of perinatal asphyxia (table 3), two with large intra- or extracerebral bleeds, two with 
suspected metabolic/genetic disorders and one a chromosome 15 (15q11.2) deletion. In summary, 
only 2% of the children were on regular AEDs at two years increasing to 7% at 4-8 years. A total of 14 
children were diagnosed with epilepsy (ILAE) in early school age.  
Early childhood seizures, other neurodevelopmental outcomes and MRI findings  
Cerebral palsy 
Twenty-two (15%) of 134 survivors were diagnosed with CP by 2 years, nine of whom had childhood 
seizures. Most children had mild forms of CP, being able to walk23. Children with CP were more likely 
to present with signs of seizures (9/14; 64%) than those who did not (13/120; 11%) (p<0.001). 
Details of the individual children (n=14) with post-neonatal seizures, their use of AEDs, CP grade, 
summated MRI scores and aEEG severity are presented in table 3.  
Neonatal seizures and use of AEDs 
Figure 1 outlines when infants seized from birth to discharge; 31 never had any documented 
seizures, 35 only seized pre-cooling, 32 only during cooling and 40 infants seized both before and 
during cooling. The majority, 113/151 (75%) of the infants had at least one seizure documented on 
aEEG and single-channel EEG before, during or after cooling. Seventy-five(50%) had single-channel 
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EEG seizures before cooling started. After day 5, all infants but 1 had stopped AEDs with no more 
seizures until discharge home or to local hospital at a median age of 9 days.   
aEEG and EEG confirmed seizures in the neonatal period were treated according to protocol. Infants 
who received 0 or 1 AEDs had similar and good outcomes (table 3). The more AEDs needed 
neonatally, the worse the outcome. The number of AEDs was used as a proxy marker for predicting 
the rate of epilepsy and poor outcome (table 4). The number and duration of seizure episodes 
recorded were less predictive than the number of AEDs used for these outcomes.    
MRI injury severity 
Table 4 shows the summated MRI scores ranging from 0-11 and the regional distribution of MRI 
brain injury in the 14 patients presenting with epilepsy. MRI scans were abnormal in 12/14 infants. 
Patients 1-8 all had a BGT predominant pattern of injury. Those needing AEDs had more severe MRI 
scores than those not needing AEDs, median (IQR) 9(4-11) vs. 2(0-7) P<0.001. The 8 infants who 
were diagnosed with epilepsy before the age of 2, had significantly worse median(IQR) MRI scores 
9(8-11) than those who were diagnosed during childhood 2(0-4).  
Cognitive outcomes 
Table 4 shows the individual Bayley-III scores and the GMFCS grades for the 14 children with 
epilepsy. Nine had CP, five with GMFCS grade 5. Four of these 5 children were on AEDs. Their Bayley-
III CLC-scores were <55 (<-3SD). The 5th child had hypsarrythmia at 3 months but was not on 
medication by 3 years. These five children all had high MRI scores (8-11) and maximum BGT injury.  
Of the remaining 9 children, five had Bayley-III CLC scores <80 and four had composite scores in the 
normal range (85-118). It was unexpected that the CLC in two children were as high as 77 and 72 when 
their MRI scores were 7 and 9 respectively.  
Two infants had low MRI scores and unexpectedly poor outcomes. Child 11 developed mild 4-limb 
dyskinetic CP, a poor motor score of 76, CLC score of 74 as well as severe hearing loss. This child had 
one seizure during cooling and one after rewarming, treated with phenobarbitone. Pre-cooling aEEG 
pattern was burst suppression and it took 48 hours before the background pattern normalised, a poor 
prognostic factor24 in addition to hypoglycaemia at birth of 1.3 mmol/L. Child 12 had a CLC of 78 and 
motor score of 61 but not CP. He had one episode of EEG confirmed clinical seizures during cooling, 
which responded quickly to phenobarbitone. His glucose at birth was low at 2.5mmol/L. Pre-cooling 
aEEG was burst suppression which did not recover to normal voltage for 72 hours. His trachea-
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oesophageal fistula was operated on during cooling. A genetic syndrome is still being sought. He 
presented with seizures at 4 years and is now seizure-free on carbamazepine.    
In summary, 10/14(71%) children with an epilepsy diagnosis up to the age of 8 years had adverse 
outcomes in other domains in comparison to 23/120(19%) of surviving infants without seizures.        
Discussion  
We have followed a 7-year clinical cohort of infants for at least 2 years and most for longer. All were 
treated with TH after moderate or severe perinatal asphyxia. Hypothermia is neuroprotective in 
particular for injury of hypoxic-ischemic origin if started within six hours of birth.  Diagnoses other 
than HIE usually come to light after TH has started, and a clinical cohort will always include some 
infants with other diagnoses as presented here.  Many centres do not use aEEG as a selection 
criterion for cooling and in a recent paper with only post-hoc aEEG analysis, 30% of cooled infants 
had a normal aEEG 25. This means that many cooled cohorts are milder than those presented in the 
randomised trials and comparing outcomes between cohorts without severity classification of aEEG 
will be misleading. Using aEEG severity at entry is the best variable for classifying HIE severity when 
cooling starts24; 25. In an ideal world, all HIE infants should have multi-lead continuous EEG 
monitoring, but this is not feasible for most centres. In 2014 Glass et al26 reported a US 3-centre 
retrospective study where infants had undergone continuous video-EEG (aEEG) starting at a median 
age of 9.5h(IQR 6.3-14.5h), i.e. after cooling started so these data cannot be compared with respect 
to seizures before cooling.  They report a normal background EEG in 34 infants, excessive 
discontinuity in 20 and severe abnormality in 30 infants; 49% of their infants had clinical seizures 
before monitoring started. We cannot compare our background aEEG pattern with this study as our 
infants were monitored much earlier and those with a normal aEEG pattern before 6 hours(8%) were 
not included in the main analysis whereas Glass et al included all patients as they do not use EEG as 
a recruitment criterion.  However, they report that 48% had seizures during or after cooling, very 
similar to us with 49% (table 3). Additionally, their cohort is of similar severity to ours.  
Historically, and also used in the large cooling trials3-5 neonatologists have used a pragmatic 
definition of epilepsy – the regular use of AEDs at the age of 2 years as well as at 5-7 years follow-
up 4. We now present results adding the newer ILAE epilepsy definition8 which doubles the number 
of cooled children having a diagnosis of epilepsy. In our cohort only 2% of children were on AEDs at 2 
years but this had increased to 7% by 4-8 years. A low seizure rate at 2 years amongst cooled infants 
was also found in Glass et al´s study26. In the major trials the number of infants on AEDs at 18 
months in the cooled group was 15% (CoolCap), 17% (NICHD) and 10% (TOBY) and the 
corresponding values in the standard treatment groups were 16%, 22% and 14%. In contrast to our 
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data, school-age follow-up in the NICHD trial7 found that only 40% of the cooled and 50% of the non-
cooled children who had been on regular AEDs at two years continued to be so at the age of 6-7 
years. It is unknown whether different post-discharge AED prescribing practices in the US and 
Europe after neonatal seizures has affected these numbers. The clinical severity of HIE assessed by 
entry criteria A in our cohort, was milder with regard to Apgar scores compared to the first cooling 
trials3-5. In addition, when comparing the aEEG voltage pattern at entry (criterion C), the proportion 
with a severe pattern was 60% in TOBY, 40% in CoolCap and 34% in our cohort indicating we have a 
milder cohort (Table 5, appendix).  However, as aEEG was a new tool to the 60 NICU’s recruiting for 
the named trials, ideally their aEEG severity scoring should be validated. At that time, many aEEGs 
were paper traces running at 6cm/h without concurrent raw EEG traces unlike today’s digital aEEGs. 
Therefore, re-analysis of the entry aEEG in the CoolCap and TOBY trials has been difficult. Clinical 
seizures only will underestimate the seizure burden, a seizure study27 in term infants recorded 
simultaneous 16 lead EEG and video for 72h and only  9% of electrographic seizures were 
accompanied by documented  clinical manifestations. Despite our milder cohort, the incidence of 
neonatal seizures (clinical and aEEG) was comparable to CoolCap and TOBY. Overall, 83% of infants 
had seizures in the CoolCap trial (recruiting 1999-2002), 77% in the TOBY trial (recruiting 2002-2006) 
and 77% in this study recruiting 2006-2013 (Table 5). 
The duration of continuous recording is long in our cohort (>78h) and in particular we start aEEG 
early from around 1h hence we detect seizures early. It is, however, interesting that 43% of infants 
with neonatal seizures before 6h in our study did not have any further seizures which carried the 
same good prognosis as the group who never had any seizures at all.  
After having investigated the safety of the 3-day CoolCap protocol before the trial commenced10 , we 
developed a local cooling treatment protocol where all at-risk infants are passively cooled while 
being investigated before deciding to start active cooling. Passive cooling was started at a median 
age of 0.75 hours. We found better motor, but not cognitive outcome in infants who starting cooling 
early (<3 hours) as compared to between 3-6 hours28. No child was ever hyperthermic (>38°C before 
cooling (Table 1)). Our ventilator strategy is to give as little oxygen as possible to keep normal 
saturations, keep pCO2 values in the high normocapneic range29 avoiding hypotension29. We use 
aEEG monitoring to recruit to TH, to classify infants into severity groups and to direct seizure care; 
we give AEDs for both clinical and electrographic seizures with a low treatment threshold. We 
suggest that be able to apply and read an aEEG at a basic level to assess background voltage and 
aEEG patterns with single-channel EEG for seizure occurrence should be a necessary skill in 
neonatology. We can only speculate that the combined brain oriented clinical management and 
early cooling have reduced the rates of post-neonatal epilepsy. On the other hand, our cohort is 
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somewhat milder than the large trials, and severe brain injury is likely less. Experimentally, Alistair 
Gunn claims that the frequency and amplitude characteristic of seizures while cold is not harmful per 
se30. In a Dutch pre-cooling study, a lower incidence of childhood epilepsy was seen in children 
whose electrographic and clinical seizures were treated compared to only treating clinical seizures31. 
However, our study cannot provide direct evidence that treating electrographic seizures benefits 
infants long-term; neither do we know whether only treating acutely and not giving maintenance 
AEDs after discharge is beneficial.  
Most AEDs are metabolised in the liver and drug metabolism is generally reduced at low core 
temperature32. There has been no change in AED regimes since TH was introduced in our cooling 
centre except for reduced use of paraldehyde, which is no longer available and reduced dosages of 
lidocaine33. It is reasonable to suggest that prolonged higher AED plasma levels are present in cooled34 
compared to normothermic infants although we do not know of the clinical impact.  
Neonatal brain MRI has proven useful in defining injury severity in HIE and understanding causation 
of neonatal seizures35; 36. Children diagnosed with epilepsy in our study had a high MRI lesion load 
consistent with Martinez-Biarge et al’s finding that “30-40% of non-cooled children with epilepsy had 
basal ganglia and thalamic lesions”37. Children who develop CP after perinatal asphyxia are at high risk 
of developing epilepsy38. Studies investigating epilepsy in children with CP have reported that 35-43% 
developed seizures in the post-neonatal period39-42, very similar to our cohort where 9 of 23 infants 
with CP(39%) developed seizures. However, variations in seizure definition and severity of HIE make 
direct comparisons between studies a challenge.  
Ten of the 14 children with epilepsy had a Bayley-III CLC score <85.This is consistent with a Swedish 
study showing that epilepsy is associated with decreased cognitive function in children with CP39.  
From our study of infants cooled for neonatal encephalopathy, we conclude that we have a very low 
incidence of childhood epilepsy at 2 years but this rate increases as the children reached 4-8 years. 
Five infants had other factors that came to light during or after cooling therapy including a defined 
chromosomal abnormality and two suspected genetic or metabolic conditions. The encephalopathy 
seen may not be only due to hypoxic-ischemic causes. Long-term follow-up is needed to determine 
final epilepsy rates and collaborative studies on optimal treatment regimens as the children mature.   
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Table 1 Demographic and cooling related information on all 165 infants 
Values are median (IQR), unless indicated. n=151    correctly recruited to TH - 
abnormal aEEG background 
voltage prior to cooling 
n=14 incorrectly recruited to TH– 
normal aEEG background voltage 
prior to cooling. 
Outborn % 47 57 
Gestational age in weeks  40.3 (38.3-40.7) 40.15 (39.3-40.8) 
Male % 62 57 
Birth weight (centile) 25 (9-75) 63 (31-75) 
Apgar score at 10 minutes  6 (4-8) 7 (6-8) 
Worst pH within the 1st hour after birth 6.94 (6.82-7.07) 6.94 (6.90-6.99) 
Worst base deficit within the 1st hour after birth 15.5 (12-20.5) 14.8 (12.5-16.1) 
Number of infants with seizures before cooling (%) 84 (56) 0 (0) 
Passive cooling commenced (age in hours) 0.75 (0.16-3.43) 0.94 (0.14-3.23) 
Active cooling commenced (age in hours) 3.78 (2.02-5.83) 5.41 (3.77-6.07) 
Age when the target temperature was achieved (hours) 4.75 (2.87-7.23) 5.22 (4.95-6) 
Highest temperature (°C )  before active cooling commenced 34.6 (33.0-36.1)°C 35.4 (34.1-36.0)°C 
Deaths number (%) 17 (11%) 0 (0%) 
 
aEEG:  amplitude-integrated EEG             TH:      therapeutic hypothermia 
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Table 2 shows the aEEG data, in the second column, classified using the voltage method from a single-channel aEEG13 and in the third 
column classified from the aEEG background pattern24 with increasing aEEG severity before active cooling started in all 165 infants. The 
number of patients with an adverse outcome (binary) for each background pattern category is shown in the fourth column. The fifth 
column lists how many infants had any type of post neonatal seizures in each aEEG pattern category.  
An adverse outcome is defined as death or disability by 18-24 months of age (see methods). A good outcome is defined as having no 
adverse outcomes.              
 
aEEG 
pattern 
(criterion 
C) prior 
to active 
cooling 
in 165 
infants  
Voltage classification  pattern  
Number (percentage)   
n=165 (100%) 
 aEEG background pattern classification  
Number (percentage)  
n=165 (100%) 
Number of children 
with an adverse  
developmental 
outcome in each 
pattern group  
Number of children 
with childhood 
seizures in each aEEG  
pattern group 
Normal voltage   14 (8%) Continuous Normal Voltage (CNV) 
only* 
14 (8%)       0(0 %) 0(0 %) 
 
Moderately abnormal 
voltage 
 
129(78 %) 
CNV With electrographic Seizures  18 (12 %)     1(6 %)                0 (0 %) 
Discontinuous Normal Voltage 38 (23 %)       8(21 %) 1 (3 %) 
Burst Supression 73 (44 %)      24(33 %)    9 (12 %) 
 
Severely abnormal 
voltage 
 
22(14 %) 
Low Voltage 7 (4 %)      4(57 %)   1(14 %) 
Flat Trace 15 (9 %)    13(87 %)    3 (20 %) 
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*When the aEEG was reassessed off line, 14 infants (8% of the cohort) had a normal aEEG background pattern (CNV) without seizures and did not fulfill the 
third criterion for therapeutic hypothermia treatment. *These 14 are excluded in some of the later analysis.  
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Table 3: A summary of the neurology information in the 14 children who were diagnosed with epilepsy according to the definition by the International League 
against Epilepsy (ILAE) at 2 years or by 4-8 years 
Patient 
number 
MRI  
score 
(0-11) 
Affected 
brain 
regions MRI 
GMFCS 
score 
(0-5) 
Severe 
hearing 
loss 
ILAE 
definition 
epilepsy 
age <2 
years (on 
set age) 
On 
AEDs 
at   2 
years 
ILAE 
definition 
epilepsy 
after 2 
years  
On 
AEDs 
at 4-8 
years 
Bayley-III 
composite 
cognitive-
language 
/motor 
scores at 
18-24 
months 
Number of 
AED Used 
*On set 
aEEG 
pattern 
prior to 
cooling 
TTNT 
aEEG 
pattern 
Other known 
diagnosis 
1 11 BGT, PLIC, 
WM and 
Cortex 
5 yes 1 month ✓   <55/<46 3        FT     >84h      major 
intracranial 
hemorrhage 
2 11 BGT, PLIC, 
WM and 
Cortex 
5 no    1 month ✓   <55/<46 5 FT >84h  
3 10 BGT, PLIC, 
WM and 
Cortex 
5 no 6 months ✓   <55/<46 4 LV >84h  
4 9  BGT, PLIC, 
WM and 
Cortex 
2 no   1 year?   ✓ 72/79 4 BS 82h cooled at 12h 
delayed decision 
5 9 BGT, WM, 
PLIC and 
Cortex  
5 no 4 months#    <55/<46 5 BS 169h  
6 8 BGT, WM, 
PLIC and 
Cortex 
5 no   2.5 ✓ <55/<46 2 BS 21h  
7 7 BGT, PLIC, 
WM and 
Cortex 
0 yes   5.5  77/76  1 FT >84h metabolic^ 
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8 4 WM, BGT, 
PLIC 
 
0 no   7 ✓ Global 
delay,  
not tested  
0 BS 8h chromosomal^^ 
9 4 Cortex, WM 0 yes   6.5  93/97 2 BS 36h  
10 3 Cortex, WM 
 
1 no 6 months    94/82 5 BS >84h major 
intracranial 
hemorrhage 
11 2 WM 
 
 
1 yes   4.5  74/76 1 BS 48h  
12 2  WM 0 no   4 ✓ 78/61 1 BS >84h chromosomal¤ 
13 0 none 1 No <1 year    91/82 1 BS 15h  
14 0 none 0 No 1 year    118/112 1 DNV 0h  
 
*Time to recovery of the aEEG trace to a normal (for being cooled) pattern. TTNT >48h predicts poor outcome 24 
AEDs: Anti-Epileptic Drugs, MRI: Magnetic Resonance Imaging  
# hypsarrythmia, ^metabolic disease under investigation, ^^ chromosome deletions (15q11.2),   ¤ chromosomal condition under investigation 
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Table 4: The number of anti-epileptic drugs (AEDs) used in the neonatal period in relation to neuro-
developmental outcome at 18 months in 151 infants undergoing therapeutic hypothermia. 
Number of 
AEDs used 
until neonatal 
discharge 
Total 
number of 
infants in 
the group 
Number 
with a 
good 
outcome 
Number  of 
survivors  
with adverse 
outcome       
Number   
died 
Total % with 
adverse 
outcome* 
 
Escalating drug protocol for treating seizures (clinical 
with or without aEEG/EEG confirmation) in cooled 
infants  
0   38 31 6                       1 7/38       18%    none 
1  60 46 8                       6 14/60     23%    20/kg phenobarbitone (1 or 2 doses) 
2  20 11 5                       4 9/20       45%    + 20mg/kg phenytoin (1 dose) 
3   19 9 6                       4 10/19     53%   + 100 mg/kg clonazepam (1/2 doses) 
4   12 4 6                       2 8/12        67%    + continuous lidocaine or midazolam infusion or both 
5 2 0 2                      0 2/2        100%  + paraldehyde 3mg/kg up to 6 hourly 
Total number 
of infants  
151 101 33                  17 50/151   33%  
 
*An adverse outcome was defined as death or disability; disability as defined as having a Bayley-III scores <85 for at least one of the 
average of Cognitive and Language composite or Motor Composite and/or cerebral palsy with a Gross Motor Function Score of 3-5 
or severe visual deficits or bilateral hearing loss requiring hearing aids 
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Table 5: aEEG background voltage before cooling in two multicenter clinical trials and this study   (Appendix) 
 
Studies CoolCap TOBY This study 
Normal aEEG background (voltage criteria)13  4% 0% 8% 
Normal aEEG background with EEG seizures 6% 0% 12% 
Moderately abnormal aEEG background 54% 40% 66% 
Severely abnormal aEEG background 36% 60% 14% 
Seizures prior to decision to give therapeutic 
hypothermia at 6 hours 
59%* 56%$  54%$ 
 
*Pre-randomisation aEEG and single-channel EEG with seizures          $Clinical and/or aEEG documented seizures  
 
 
 
 
 
 
 
 
